Articles & guides — page 8
125 cited, vendor-independent pieces on the questions people actually ask — reconstitution and handling, half-lives, compound comparisons, and how to track a protocol. Research and education only; never dosing advice, never sourcing.
125 articles
What is orforglipron?
Orforglipron explained: the oral small-molecule (non-peptide) GLP-1 receptor agonist, why being a small molecule matters, its phase-3 weight-loss and HbA1c results, and its status.
Human clinical dataCompound overviews4 minWhat is VK2735?
VK2735 explained: Viking Therapeutics' GIP/GLP-1 receptor dual agonist, its fast phase-2 VENTURE weight-loss results, its subcutaneous and oral forms, and its status.
Human clinical dataCompound overviews4 minWhat is pemvidutide?
Pemvidutide explained: the GLP-1/glucagon dual agonist, why the glucagon arm targets both body weight and liver fat, its MASLD trial results, and its status as an investigational drug.
Human clinical dataCompound overviews6 minWhat is hexarelin?
Hexarelin explained plainly: a potent GHRP-family growth-hormone secretagogue with a second, heart-specific receptor (CD36), what human GH studies and animal cardiac studies actually showed.
Human clinical dataCompound overviews6 minWhat is IGF-1 LR3?
IGF-1 LR3 explained honestly: a lab-engineered, long-acting version of the growth factor IGF-1 — what animal and cell studies show, and why the missing human safety data and cancer-signaling theory matter.
PreclinicalCompound overviews5 minWhat is kisspeptin-10?
Kisspeptin-10 explained with the literature: the upstream switch that turns on the reproductive axis, what human LH, testosterone and fertility studies from the Dhillo group actually found.
Human clinical dataCompound overviews5 minWhat is gonadorelin?
Gonadorelin explained plainly: it is GnRH itself, the short-acting hormone used as a TRT adjunct, why pulses stimulate but constant exposure suppresses, and its FDA history.
Human clinical dataCompound overviews5 minWhat is SS-31 (elamipretide)?
SS-31 (elamipretide): a mitochondria-targeting peptide that binds cardiolipin, now FDA-approved for Barth syndrome but with a mixed trial record elsewhere.
Human clinical dataCompound overviews4 minWhat is humanin?
Humanin: a small peptide your own mitochondria make, discovered in 2001 and tied to neuroprotection and metabolism, but studied mostly in cells and animals.
PreclinicalCompound overviews4 minWhat is DSIP (delta sleep-inducing peptide)?
DSIP explained honestly: a nine-amino-acid peptide named for slow-wave sleep in 1977, but with old, small, inconsistent data and no proven receptor.
PreclinicalCompound overviews5 minWhat is dihexa?
Dihexa: an angiotensin-IV-derived nootropic reported to drive synapse growth in rodents, but with no human data and a retracted key mechanism paper.
PreclinicalCompound overviews4 minWhat is NAD+ injection?
NAD+ injection explained: what NAD+ actually is, why people inject it, what human trials really show (mostly for oral precursors), and where the anti-aging hype outruns the evidence.
Human clinical dataZyra Track is a research and educational utility. Nothing on this page is medical advice, a dosing recommendation, or an endorsement of any compound. We never sell or source compounds and refuse sourcing questions. Consult a qualified clinician for decisions about your health.